UltraPlasma™ Multi-Platform Plasma System for Condyloma Treatments

Combining Arc, Argon, and Helium Plasmas with Unique Software and Hardware Output Spectrum

Introduction

Condylomas, or genital warts, caused by Human Papillomavirus (HPV), represent a persistent dermatological and immunological challenge due to their recurring nature and viral etiology. UltraPlasma™ introduces a revolutionary approach by combining Arc Plasma, Argon Plasma, and Helium Plasma in a synchronized system enhanced by proprietary software-defined modulation and hardware-tuned spectral emission. This advanced therapy platform targets condyloma lesions across epidermal, dermal, and hypodermal layers while optimizing gaseous interactions such as ozone (O₃), nitric oxide (NO), reactive oxygen species (ROS), and reactive nitrogen species (RNS).

1. Technology Integration: Arc, Argon, and Helium Plasmas

1. UltraPlasma™ Arc Plasma Mode (High-Energy Discharge)

• Penetrates hyperkeratotic warts.

• Thermally denatures viral proteins.

• Initiates local necrosis and desiccation of infected tissue.

2. UltraPlasma™ Argon Plasma Mode (Cold Directed Stream)

• Enables low-temperature ionization over sensitive mucosal regions.

• Enhances surface sterilization.

• Induces controlled ROS production, lethal to viral particles.

3. UltraPlasma™ Helium Plasma Mode (Precision, Low-Ion Mass)

• Allows pinpoint targeting on vascularized wart regions.

• Increases microcirculatory stimulation.

• Improves healing by upregulating oxygenation and fibroblast activity.

2. Plasma Interaction with Skin Layers and Blood Functions

Epidermis

• Direct ablation of HPV-infected keratinocytes.

• NO and O₃ act as antiviral agents, destroying viral capsids.

• Plasma microjets clean and sterilize the lesion area.

Dermis

• Indirect immune activation through RNS exposure.

• Stimulation of Langerhans cells, enhancing localized immune memory.

• Promotion of angiogenesis and dermal remodeling.

Hypodermis

• Thermal penetration to subcutaneous vessels stimulates systemic cytokine signaling.

• Helium-supported plasma exposure increases vascular nitric oxide levels, improving blood perfusion and systemic immunity.

3. Gas Emission & Immune Modulation

4. UltraPlasma™ Multi-Gas Emission Spectrum

5. Before and After UltraPlasma™ Treatment on Condyloma

• Day 0: Hypertrophic wart lesions.

• Day 7: Shrinkage and necrosis.

• Day 21: Re-epithelialization, restored dermal tone.

⌘Conclusion⌘

UltraPlasma™ offers a paradigm shift in the treatment of all condyloma types, combining precise plasma technologies with biologically relevant gas outputs. By activating skin immunity, destructing infected tissues, and boosting systemic response, it offers a non-invasive, pain-controlled, and clinically effective solution for wart management.

Shortcut for our Goals!

▼